![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print December 22, 2006
Oklahoma Medical Research Foundation, Oklahoma City, OK 73104
Corresponding Author: Myron-Hinsdale{at}omrf.ouhsc.edu
Xylosyltransferase (XylT) catalyzes the initial enzymatic reaction in the glycosaminoglycan assembly pathway for proteoglycan biosynthesis. Its activity is thought to be rate limiting. Two xylosyltransferases have been found using genomic analyses and one of these, XylT1, has been shown to have xylosyltransferase activity. On the other hand, the less studied XylT2 in recombinant form lacks xylosyltransferase activity and has no known function. Wild-type Chinese hamster ovary (CHO) cells express abundant Xylt2 mRNA levels and lack detectable Xylt1 mRNA levels. Analysis of a previously described CHO cell xylosyltransferase mutant (psgA-745) shows that it harbors a Xylt2 nonsense mutation and fails to assemble glycosaminoglycans onto recombinant biglycan. Transfection of this cell line with a murine Xylt2 minigene results in the production of recombinant chondroitin sulfate modified biglycan core protein and restoration of fibroblast growth factor binding to cell surface associated heparan sulfate. Expression analyses on 10 different human transformed cell lines detects exclusive XYLT2 expression in 2 and co-expression of XYLT1 and XYLT2 in the others, but at disparate ratios where XYLT2 expression is greater than XYLT1 in most cell lines. These results indicate that XylT2 has a significant role in proteoglycan biosynthesis and that cell type may control which family member is utilized.
J. Biol. Chem, 10.1074/jbc.M611048200
Submitted on November 30, 2006
Revised on December 18, 2006
Accepted on December 22, 2006
Biosynthesis of chondroitin and heparan sulfate in CHO cells depends on Xylosyltransferase II
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. Prante, H. Milting, A. Kassner, M. Farr, M. Ambrosius, S. Schon, D. G. Seidler, A. E. Banayosy, R. Korfer, J. Kuhn, et al. Transforming Growth Factor beta1-regulated Xylosyltransferase I Activity in Human Cardiac Fibroblasts and Its Impact for Myocardial Remodeling J. Biol. Chem., September 7, 2007; 282(36): 26441 - 26449. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Condac, R. Silasi-Mansat, S. Kosanke, T. Schoeb, R. Towner, F. Lupu, R. D. Cummings, and M. E. Hinsdale Polycystic disease caused by deficiency in xylosyltransferase 2, an initiating enzyme of glycosaminoglycan biosynthesis PNAS, May 29, 2007; 104(22): 9416 - 9421. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Voglmeir, R. Voglauer, and I. B. H. Wilson XT-II, the Second Isoform of Human Peptide-O-xylosyltransferase, Displays Enzymatic Activity J. Biol. Chem., March 2, 2007; 282(9): 5984 - 5990. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |